BioXpress Therapeutics SA
Description
BioXpress Therapeutics SA is a premier provider of high-quality biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. We have made a commitment to be your partner of choice for the full development of your biosimilar biologic API. BioXpress Therapeutics is focused on developing the highest quality product under strict European Medicines Agency (EMA) guidelines. We bring together the world’s top biologic development, manufacturing and regulatory experts dedicated to your project.
Tell your friends
RECENT FACEBOOK POSTS
facebook.comBioXpress Newsroom
Partnership Agreement BioXpress Therapeutics SA closed its sixth partnership agreement. This agreement extends the partnership with a Southeast Asia Partner to enable access to oncology drugs at throughout Southeast Asia at a reasonable cost.
Quiz
